Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beth Israel Deaconess Medical Center, Boston, U.S.
Studies from Beth Israel Deaconess Medical Center, Boston, U.S. highlight latest findings
November 7th, 2006
Studies from Beth Israel Deaconess Medical Center, Boston, U.S. highlight latest findings. This trend article about Beth Israel Deaconess Medical Center, Boston, U.S. is an immediate alert from LawRx to identify developing directions of research. Study 1: Performance of mandatory angiographic followup increases rates of target vessel revascularization among patients receiving both bare-metal stents and paclitaxel-eluting stents (PES) and overestimates the absolute clinical benefits of PES relative to clinical followup alone. According to recent research from the United States, "The objectives of the study were to evaluate the...
Source: Drug Law Weekly (2006-11-07)
|